Skip to main content

Ontario BMD Testing

Changes in BMD Testing in Ontario

The Ontario Health Insurance Plan (OHIP) Schedule of Benefits mandates health services reimbursement in the province of Ontario. As of April 1, 2026, significant changes were implemented, affecting access to Bone Mineral Density (BMD) testing in Ontario.

Osteoporosis Canada wants you to be aware of these changes as they will affect how you and your health care provider move forward when planning your bone health strategy.

Osteoporosis Canada does not think that the current access as outlined by OHIP is consistent with the Osteoporosis Canada 2023 Clinical Practice Guideline for the Management of Osteoporosis in Canada and is not in the best interests of patient care. 

Prior to April 1, 2026, physicians were provided with guidance from OHIP regarding the frequency of bone density testing in different clinical situations but were granted the opportunity to use their expertise to determine which patients were low risk (and therefore did not need frequent BMD monitoring) and which patients were of higher risk, benefiting from more frequent assessment. A repeat BMD was permitted 12 months after a previous test, if this was deemed necessary for high risk individuals by the health care provider.

As of April 1, 2026, OHIP stipulates that the ability to obtain a baseline BMD remains based on a healthcare provider’s assessment. However, the timing of the follow-up BMD is based on OHIP’s definition of patient risk. These new criteria used by OHIP are different from the generally accepted clinical risk factors used by health care providers across Canada, thereby limiting clinical appropriate access to necessary BMD testing for patients in Ontario. 

Progress To Date

  • Physician representatives from Diagnostic Imaging, Nuclear Medicine, Rheumatology and Endocrinology have met with officials from the Ministry of Health and Ontario Medical Association to discuss their concerns.
  • Negotiations are in progress, with positive steps being discussed although a clear resolution is yet to be determined.

Read the full April 7, 2026 Rapid Response Here: https://osteoporosis.ca/latest-news/changes-in-bmd-testing-in-ontario-hp/

Read the full April 24, 2026 Rapid Response Here: https://osteoporosis.ca/latest-news/changes-in-bmd-testing-in-ontario-an-update/

Did You Know

  • The current access as outlined by OHIP is not consistent with the Osteoporosis Canada 2023 Clinical Practice Guideline for the Management of Osteoporosis in Canada and is not in the best interests of patient care.
  • Many Ontarians have had their BMD tests cancelled since April 1, 2026.  
  • The new OHIP BMD criteria has neglected those who have other secondary causes for rapid bone loss including Cancer Chemotherapy, Rheumatoid Arthritis, Diabetes, Parkinson’s Disease and Multiple Sclerosis.
  • Self funding of bone density testing is not allowed under OHIP rules.

What This Means

  • While discussions are occurring, a resolution to this issue needs to be well thought out and may take time.
  • Until a solution is agreed upon – interim or long-term, many BMD tests will continue to be cancelled and could be delayed for up to 3 years. 
  • This has a potentially negative impact on patient care. 
    • An estimated 500,000 BMD tests were performed in Ontario in 2005 or an average of about 10,000 tests per week. This number has surely increased and is much higher in 2026.
    • As more BMD tests are cancelled, there is risk of more doctor visits being deferred, resulting in potential increased risk to optimal patient care.

What You Can Do – Use Your Voice!

The Ministry of Health has heard from experts in the field but patient voices are needed.

Send a Message to Premier Doug Ford, Minister of Health, Sylvia Jones, Patrick Dicerni, Assistant Deputy Minister, Health Programs and Delivery Division, Ontario Ministry of Health and your local Member of Provincial Parliament (MPP) to restore access to Testing in Ontario and to Stop the Cancellation of BMD Appointments while negotiations are in progress for a solution.

Thank you for your support.  A positive outcome has been reached for BMD testing in Ontario.

© Osteoporosis Canada, 2026
Charitable Registration No. 89551 0931 RR 0001